You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TB Alliance

Showing 1 - 25 of 1,261
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

Not yet recruiting
  • Tuberculosis
  • Rifampicin Resistant Tuberculosis
  • Pretomanid
  • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
  • Rio De Janeiro, Brazil
  • +6 more
Oct 18, 2022

Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

Not yet recruiting
  • Pulmonary Tuberculosis
  • (no location specified)
Oct 27, 2023

Tuberculosis Trial in Mozambique, South Africa, Tanzania (Sutezolid, N-acetyl cysteine, Pretomanid)

Not yet recruiting
  • Tuberculosis
  • Maputo, Mozambique
  • +3 more
Jan 13, 2023

Tuberculosis, Meningeal, Linezolid Trial in Bandung (Linezolid)

Recruiting
  • Tuberculosis, Meningeal
  • Linezolid
  • Bandung, Jawa Barat, Indonesia
    Hasan Sadikin General Hospital
Aug 7, 2022

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Recruiting
  • Drug Resistant Tuberculosis
  • +3 more
  • Xpert® MTB/XDR
  • Gulele, Addis Ababa, Ethiopia
  • +3 more
Jun 13, 2022

Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

Active, not recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +4 more
May 12, 2021

HIV, Tuberculosis Trial in United States (Isoniazid, Pyridoxine HCl)

Completed
  • HIV Infections
  • Tuberculosis
  • Los Angeles, California
  • +13 more
Oct 27, 2021

HIV, Tuberculosis Trial in United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

Completed
  • HIV Infections
  • Tuberculosis
  • San Francisco, California
  • +24 more
Oct 26, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

Health Behavior Trial (Connect2Test Intervention)

Completed
  • Health Behavior
  • Connect2Test Intervention
  • Eugene, Oregon
    University of Oregon
Oct 12, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

Recruiting
  • Tuberculosis, Pulmonary
  • +4 more
  • Johannesburg, South Africa
  • +2 more
Oct 4, 2021

MDR-TB, HIV Trial in South Africa (NCM-Plus)

Active, not recruiting
  • MDR-TB
  • HIV
  • NCM-Plus
  • Westville, Durban, South Africa
  • +14 more
Nov 16, 2021

Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)

Completed
  • Pulmonary Tuberculosis
  • Ysterplaat, Cape Town, South Africa
  • +2 more
Nov 19, 2020

Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

Recruiting
  • Tuberculosis
  • +2 more
  • Observational PK study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Dec 21, 2022

NSCLC Trial in Worldwide (DS-1062a)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Phoenix, Arizona
  • +82 more
Jul 27, 2022

Tuberculosis, Extrapulmonary Trial in South Africa, Zambia, Zimbabwe (IRISA-TB)

Recruiting
  • Tuberculosis, Extrapulmonary
  • IRISA-TB
  • Durban, KwaZulu-Natal, South Africa
  • +3 more
Nov 13, 2023

Tuberculosis Trial in Uganda (SMS, Phone call, Mobile money incentive)

Not yet recruiting
  • Tuberculosis
  • SMS
  • +2 more
  • Luwero, Kasana, Uganda
  • +4 more
Jul 19, 2023

Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)

Not yet recruiting
  • Tuberculosis
  • Quantiferon Gold
  • +5 more
  • (no location specified)
Oct 27, 2023

Tuberculosis, Diagnostics, Global Health Trial in Maputo, Cape Town, Kampala (Oral swab molecular testing, Automated Cough Sound

Not yet recruiting
  • Tuberculosis
  • +2 more
  • Oral swab molecular testing
  • +3 more
  • Maputo, Mozambique
  • +2 more
Aug 9, 2023

Tuberculosis Trial in Abuja, Dasmariñas, Lusaka (Tongue swab-based molecular assays)

Not yet recruiting
  • Tuberculosis
  • Tongue swab-based molecular assays
  • Abuja, Nigeria
  • +2 more
Jul 11, 2023

The INSTITUT Study

Recruiting
  • Tuberculosis, Pulmonary
  • Undernutrition
  • Nutritional support
  • Porto-Novo, Benin
  • +1 more
Oct 12, 2023